Skip to Content
Merck
  • Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.

Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.

Science (New York, N.Y.) (2023-09-14)
Robin J Dart, Iva Zlatareva, Pierre Vantourout, Efstathios Theodoridis, Ariella Amar, Shichina Kannambath, Philip East, Timothy Recaldin, John C Mansfield, Christopher A Lamb, Miles Parkes, Peter M Irving, Natalie J Prescott, Adrian C Hayday
ABSTRACT

Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in humans, we characterized the colonic γδ T cell compartment, identifying a diverse repertoire that includes a phenotypically distinct subset coexpressing T cell receptor Vγ4 and the epithelium-binding integrin CD103. This subset was disproportionately diminished and dysregulated in inflammatory bowel disease, whereas on-treatment CD103+γδ T cell restoration was associated with sustained inflammatory bowel disease remission. Moreover, CD103+Vγ4+cell dysregulation and loss were also displayed by humans with germline BTNL3/BTNL8 hypomorphism, which we identified as a risk factor for penetrating Crohn's disease (CD). Thus, BTNL-dependent selection and/or maintenance of distinct tissue-intrinsic γδ T cells appears to be an evolutionarily conserved axis limiting the progression of a complex, multifactorial, tissue-damaging disease of increasing global incidence.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Milli-Mark® Anti-FcεRI Antibody, γ subunit-FITC, Milli-Mark®, from rabbit